Orphan designation: spironolactone Treatment of central serous chorioretinopathy, 09/01/2026 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 April 2026 - 14:55

Orphan designation: spironolactone Treatment of central serous chorioretinopathy, 09/01/2026 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3193

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters